abstract |
The purpose of the present invention is to safely treat or prevent, without difficulties in drug selection or dose design and without side effects, developmental disorder, schizophrenia, mood disorder, eating disorder, a mental disease following cerebrovascular disorder or a mental disease following head trauma, and to potentiate the effect of a therapeutic for cognitive impairment or an antidepressant. A medicinal composition according to the present invention, which comprises, as the active ingredient, at least one compound selected from the group consisting of ferulic acid, an ester thereof, a pharmacologically acceptable salt of the same and a pharmacologically acceptable solvate of the same, can be used, either alone or in combination with an active ingredient of a therapeutic for the aforesaid diseases or disorders, for treating the diseases or disorders. |